Chi, Margaret
Katuwal, Nishan
Shrestha, Aastha
Madhup, Surendra Kumar
Tamrakar, Dipesh
Shrestha, Rajeev
Funding for this research was provided by:
Fulbright Program, United States (PS00354051)
Bill and Melinda Gates Foundation, United States (INV008942, INV008942, INV008942, INV008942, INV008942)
Article History
Received: 18 September 2024
Accepted: 10 February 2025
First Online: 6 March 2025
Ethics approval and consent to participate
: Ethical approval for this study was obtained by the Ethical Review Board at Nepal Health Research Council (NHRC ERB, ref.: 107/2023) and Institutional Review Committee at Kathmandu University School of Medical Sciences (KUSMS IRC, ref.: 117/2024). This study did not directly contact the human subjects or patients and only investigated banked serum samples obtained during routine dengue diagnostic procedures with secondary metadata obtained from hospital’s EMR. Therefore, informed consent from the patients was waived by the NHRC ERB and the KUSMS IRC. We declare that all research conducted in the study conformed to the principles of the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.